Literature DB >> 18385606

Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report.

Junpei Soeda1, Masahide Yazaki, Takenari Nakata, Shiro Miwa, Shu-ichi Ikeda, Waki Hosoda, Mikio Iijima, Keiko Kobayashi, Takeyori Saheki, Masamichi Kojiro, Shin-ichi Miyagawa.   

Abstract

We report a 50-year-old male patient with primary liver carcinoma exhibiting dual hepatocellular and biliary epithelial differentiations associated with citrin deficiency (asymptomatic adult-onset type II citrullinemia, CTLN2). Although so far 14 CTLN2 patients with hepatocellular carcinoma have been reported, this report describes a unique case of liver carcinoma showing the features of both hepatocellular and cholangiocellular carcinoma. In addition to the clinical data of the 14 patients reported previously, the findings in our patient suggest that the citrin deficiency might be one of the key disorders causing hepatocellular carcinoma especially at younger ages and can also play an important role in hepatocarcinogenesis of the hepatic progenitor cells, which have the bipotential to differentiate into both hepatocytes and cholangiocytes.

Entities:  

Mesh:

Year:  2008        PMID: 18385606     DOI: 10.1097/01.mcg.0000225683.29841.9c

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Prediction of the functional effect of novel SLC25A13 variants using a S. cerevisiae model of AGC2 deficiency.

Authors:  Parith Wongkittichote; Sumalee Tungpradabkul; Duangrurdee Wattanasirichaigoon; Laran T Jensen
Journal:  J Inherit Metab Dis       Date:  2012-10-03       Impact factor: 4.982

2.  Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.

Authors:  James M Wilson; Oleg A Shchelochkov; Renata C Gallagher; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2011-11-07       Impact factor: 4.797

Review 3.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

4.  Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency.

Authors:  Ayako Tabata; Jian-Sheng Sheng; Miharu Ushikai; Yuan-Zong Song; Hong-Zhi Gao; Yao-Bang Lu; Fumihiko Okumura; Mikio Iijima; Kozo Mutoh; Shosei Kishida; Takeyori Saheki; Keiko Kobayashi
Journal:  J Hum Genet       Date:  2008-04-05       Impact factor: 3.172

Review 5.  AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures.

Authors:  Takeyori Saheki; Mitsuaki Moriyama; Aki Funahashi; Eishi Kuroda
Journal:  Biomolecules       Date:  2020-07-24

Review 6.  Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature.

Authors:  Giovanni Vitale; Alessandro Mattiaccio; Amalia Conti; Laura Turco; Marco Seri; Fabio Piscaglia; Maria Cristina Morelli
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

7.  Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong.

Authors:  S C Chong; P Lo; C W Chow; L Yuen; W C W Chu; T Y Leung; J Hui; F Scaglia
Journal:  Mol Genet Metab Rep       Date:  2018-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.